Search Ontology:
ChEBI
alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
- Term ID
- CHEBI:71565
- Synonyms
-
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-Neu5Ac-(2->3)-beta-D-GalNAc-(1->4)-beta-D-GlcNAc
- N-acetyl-alpha-neuraminyl-(2->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
- Neu5Acalpha2-3GalNAcbeta1-4GlcNAcbeta
- O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
- Definition
- An amino trisaccharide comprised of α-neuraminic acid, N-acetyl-β-D-galactosamine and N-acetyl-β-D-glucosamine residues linked sequentially (2→3) and (1→4).
- References
-
- glygen:G95440AP
- glytoucan:G95440AP
- pubmed:19443021
- pubmed:31537530
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
Phenotype affecting alpha-Neup5Ac-(2->3)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
Human Disease Model